HER4 Isoforms: Tumor Suppressor Action and Prognostic Significance

$117,354P50FY2006CANIH

Univ Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Henry Shelton Earpcontact

Linked publications, trials & patents

Paper 39621782 Paper 39546597 Paper 39418101 Paper 39375971 Paper 39199576 Paper 39185474 Paper 39184956 Paper 39154153 Paper 39013134 Paper 39007881 Paper 38948758 Paper 38642278 Paper 38564595 Paper 38551513 Paper 38546612 Paper 38448600 Paper 38324568 Paper 38270534 Paper 38263910 Paper 38217760 Paper 38200309 Paper 38117494 Paper 38073557 Paper 38070094 Paper 38046186 Paper 37983586 Paper 37952058 Paper 37874652 Paper 37808840 Paper 37747807 Paper 37660548 Paper 37574209 Paper 37559094 Paper 37484164 Paper 37451831 Paper 37438515 Paper 37401034 Paper 37398150 Paper 37308906 Paper 37256703 Paper 37204246 Paper 37066379 Paper 37061618 Paper 37040757 Paper 36993425 Paper 36968228 Paper 36824750 Paper 36703164 Paper 36689693 Paper 36645168 Paper 36602784 Paper 36585450 Paper 36223240 Paper 36129803 Paper 36103105 Paper 36008651 Paper 35973227 Paper 35869079 Paper 35752724 Paper 35723569 Paper 35701440 Paper 35565277 Paper 35561168 Paper 35554533 Paper 35437570 Paper 35426390 Paper 35418701 Paper 35406623 Paper 35286522 Paper 35275284 Paper 35263625 Paper 35218811 Paper 35180770 Paper 35176136 Paper 35157783 Paper 35134826 Paper 35131882 Paper 35121644 Paper 35108027 Paper 35044810 Paper 35044794 Paper 35042965 Paper 35039947 Paper 35034243 Paper 35020982 Paper 35006482 Trial NCT06347068 Trial NCT03361800 Trial NCT01000883 Trial NCT00266110 Trial NCT00088985 Patent 9631239 Patent 9181588 Patent 9073982 Patent 9066963 Patent 8734789 Patent 6969760 Patent 6210654 Patent 6136595 Patent 5728536

View original record on NIH RePORTER →